eureKARE logo

eureKARE

Venture Capital

To bring disruptive technologies in health, environment and sustainability, and biomanufacturing to market.

Founded 2020 France Paris, France 1 employees Biotechnology, Finance

4

Total Investments

4

Portfolio Companies

-

Exits

2

Industries

General Information

Industries Biotechnology, Finance

Company Overview

Founded 2020
Employees 1
Location France Paris, France
Website eurekare.eu

Investment Criteria

Investment Thesis

•••••• •••••• ••••••

About eureKARE

eureKARE is an investment company focused on financing and developing synthetic biology innovation across Europe. Driven by the belief that synthetic biology holds the key to many of the world’s most pressing health and environmental challenges, eureKARE’s experienced team is focused on harnessing Europe’s untapped leadership in the field to build the companies of the future. eureKARE is championing a new model of start-up creation and development to create a dynamic ecosystem of early and later stage ventures through its network of biotech studios. eureKARE’s studios act as a bridge between academia and industry, helping to catalyze innovations into companies with access to all the ingredients they need to grow, prosper, and bring benefits to society.

Recent Investments (4)

View All
Company Stage Amount Date
Seed •••••• Nov 2022
Series C •••••• Jan 2022
Corporate Round •••••• Nov 2021
Series B •••••• Jul 2021

All startup & investor data, one platform.

Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.

Access Millions of Companies and 50K+ Investors

Signal-based outbound intelligence for sales, agencies, and investors.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes